Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics Inc
(NQ:
IOVA
)
11.40
-0.50 (-4.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street
January 08, 2024
Find out why investment bank analysts are hyperbullish for these stocks.
Via
The Motley Fool
Why Iovance Biotherapeutics Stock Popped Today
December 28, 2023
Iovance rebounded nicely after yesterday's drop, which came after the FDA put a clinical hold on its cancer-therapy trial.
Via
The Motley Fool
Exposures
Product Safety
What's Going On With Bone Biologics Corp Stock?
December 28, 2023
Bone Biologics Corp (NASDAQ: BBLG) shares are trading higher Thursday and has been halted multiple times despite a lack of company-specific news. Here's what you need to know.
Via
Benzinga
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 28, 2023
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.
Via
Benzinga
Why Iovance Biotherapeutics Stock Is Crashing Today
December 27, 2023
One of the small biotech's top pipeline programs ran into a major setback.
Via
The Motley Fool
Why Iovance Biotherapeutics Stock Is Jumping Today
November 20, 2023
Another Wall Street analyst has jumped aboard the Iovance train.
Via
The Motley Fool
Investor Sentiment Edges Lower; Dow Jumps Over 100 Points
December 28, 2023
The CNN Money Fear and Greed index showed a decline in overall market sentiment, but the index remained in the "Extreme Greed" zone on Wednesday. U.S. stocks closed higher on Wednesday, with the Dow...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher
December 27, 2023
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 27, 2023
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...
Via
Benzinga
Why Iovance Biotherapeutics Stock Is Marching Higher Today
November 08, 2023
Investors are excited by the prospects of a potential regulatory approval.
Via
The Motley Fool
Analyst Expectations for Iovance Biotherapeutics's Future
November 08, 2023
Via
Benzinga
Earnings Preview: Iovance Biotherapeutics
November 06, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 27, 2023
Via
Benzinga
Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December
December 27, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Iovance Biotherapeutics, Nio, NetEase And Other Big Stocks Moving Lower On Wednesday
December 27, 2023
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 80 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FDA Slaps Clinical Hold On Iovance Biotherapeutics' Lung Cancer Study After Patient Death
December 27, 2023
Wednesday, Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced a clinical program update for LN-145 TIL therapy in non-
Via
Benzinga
Exposures
Product Safety
US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY
December 27, 2023
U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining more than 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 37,575.13 while...
Via
Benzinga
Topics
Stocks
Exposures
Product Safety
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 27, 2023
Via
Benzinga
Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer
December 27, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
December 22, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?
December 12, 2023
Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.
Via
The Motley Fool
A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street
December 12, 2023
There's a huge gap between what the stock market and Wall Street analysts have to say about this often-overlooked growth stock.
Via
The Motley Fool
Crude Oil Gains Over 2%; PaxMedica Shares Plunge
November 20, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Monday. The Dow traded up 0.34% to 35,064.42 while the NASDAQ rose 0.80% to 14,238.67. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 20, 2023
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates...
Via
Benzinga
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
November 17, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
5 OTC Stocks With The Potential To Explode In 2024
November 08, 2023
Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.
Via
Benzinga
Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2023 Financial Results and Corporate Updates
November 07, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023
October 31, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
October 31, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.